GraphiqueCollé-3.png
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer
14 déc. 2021 02h00 HE | InnoSkel
InnoSkel Appoints Dr Sophie Amsellem-Bosq as Chief Technical Officer Nice, France, 14 December 2021 – InnoSkel (the “Company”), a pioneering platform biotechnology company developing transformative...
GraphiqueCollé-3.png
Innoskel Founder and CEO, Elvire Gouze, PhD Receives EY Entrepreneur Of The Year™ Southeast France 2021 Award
30 sept. 2021 06h00 HE | InnoSkel
Innoskel Founder and CEO, Elvire Gouze, PhD Receives EY Entrepreneur Of The Year™ Southeast France 2021 Award Award recognizes Dr. Gouze’s leadership to transform the treatment paradigm for...
GraphiqueCollé-3.png
InnoSkel Launches with €20 Million Series A Financing
14 déc. 2020 01h00 HE | InnoSkel
InnoSkel Launches with €20 Million Series A Financing Proceeds to support development and advancement of innovative gene therapies for patients with rare skeletal diseases Founded and led by...
Jeito logo.png
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders
14 déc. 2020 01h00 HE | Jeito Capital
Jeito Capital leads €20 Million Investment in InnoSkel, a New Gene Therapy Company and leader in rare skeletal disorders Jeito’s third international investment in H2 2020, with deep and rapidly...